Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Acute hepatitis C is a liver disease related to a virus: hepatitis C virus (HCV). The type of
Hepatitis C Virus present in Egypt (genotype 4), has the reputation to respond poorly to
treatment at the chronic hepatitis stage. Without treatment, 85% of patients with acute
hepatitis C become chronically HCV infected which means that the virus stays present in the
body. Pegylated Interferon is a new form of Interferon that stays in the body for longer time
and allows the patient to take less injection per week. It has also proved to be more
effective than standard Interferon in treatment of chronic hepatitis C.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis